Showing 21 - 40 results of 2,553 for search '"mRNA"', query time: 0.10s Refine Results
  1. 21

    Leveraging mRNA technology for antigen based immuno-oncology therapies by Wei Zheng, Michele Ceccarelli, Charalampos S Floudas, Siranush Sarkizova

    Published 2025-01-01
    “…The application of messenger RNA (mRNA) technology in antigen-based immuno-oncology therapies represents a significant advancement in cancer treatment. …”
    Get full text
    Article
  2. 22

    Toxic Epidermal Necrolysis after COVID-19 mRNA-1237 Vaccination by Nicole Hehr, Benjamin P. Davis

    Published 2023-01-01
    “…This letter illustrates a case of toxic epidermal necrolysis (TEN) after COVID-19 mRNA-1273 vaccination, which corresponds with the existing published data and contributes detailed knowledge of TEN reaction after vaccination. …”
    Get full text
    Article
  3. 23
  4. 24

    Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery by Wei Wang, Kepan Chen, Ting Jiang, Yiyang Wu, Zheng Wu, Hang Ying, Hang Yu, Jing Lu, Jinzhong Lin, Defang Ouyang

    Published 2024-12-01
    “…Abstract Lipid nanoparticles (LNPs) have proven effective in mRNA delivery, as evidenced by COVID-19 vaccines. …”
    Get full text
    Article
  5. 25

    Myocarditis following mRNA COVID‐19 vaccination: call for endomyocardial biopsy by Daniel Kiblboeck, Karin Klingel, Martin Genger, Selina Traxler, Nathalie Braunsteiner, Clemens Steinwender, Joerg Kellermair

    Published 2022-06-01
    “…Abstract Acute myocarditis following mRNA COVID‐19 vaccination was reported by the European Medicine Agency safety committee as a rare adverse event. …”
    Get full text
    Article
  6. 26
  7. 27
  8. 28

    SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency by Brendan Connolly, Cleo Isaacs, Lei Cheng, Kirtika H. Asrani, Romesh R. Subramanian

    Published 2018-01-01
    “…Taken together, our data suggests that SerpinA1 mRNA therapy has the potential to benefit patients suffering from AAT deficiency.…”
    Get full text
    Article
  9. 29
  10. 30

    Reduced UPF1 levels in senescence impair nonsense-mediated mRNA decay by Dahyeon Koh, Yebin Lee, Kyuchan Kim, Hyeong Bin Jeon, Chaehwan Oh, Sangik Hwang, Minjung Lim, Kwang-Pyo Lee, Yeonkyoung Park, Yong Ryoul Yang, Yoon Ki Kim, Donghwan Shim, Myriam Gorospe, Ji Heon Noh, Kyoung Mi Kim

    Published 2025-01-01
    “…These findings suggest that the decline in UPF1 levels during cellular senescence accelerates the senescent phenotype by impairing NMD activity and the consequent accumulation of abnormal mRNA.…”
    Get full text
    Article
  11. 31
  12. 32

    Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model by Yeqi Li, Suresh Ambati, Richard B. Meagher, Xiaorong Lin

    Published 2025-02-01
    “…These results support the promise of mRNA-LNP vaccines against fungal diseases.…”
    Get full text
    Article
  13. 33
  14. 34
  15. 35
  16. 36

    Decreases in mRNA by an siRNA Complex Do not Alter Blood Pressure in Mice by Su-Min Ji, Young-Bin Shin, So-Yon Park, Hyeon-Ju Lee, Bermseok Oh

    Published 2012-03-01
    “…To validate the function of CASZ1 in blood pressure, we decreased Casz1 mRNA levels in mice by siRNA. Casz1 siRNA reduced mRNA levels by 59% in a mouse cell line. …”
    Get full text
    Article
  17. 37

    Modification of Cɛ mRNA Expression by EBV-Encoded Latent Membrane Protein 1 by Kazuhiko Hanashiro, Shigeto Ohta, Masanori Sunagawa, Mariko Nakamura, Mikio Suzuki, Tadayoshi Kosugi

    Published 2006-01-01
    “…To evaluate the effect of expression of latent membrane protein (LMP) 1 encoded by Epstein-Barr virus (EBV) on Cɛ mRNA expression, mRNA levels were examined by RT-PCR or Northern blot analysis upon transient transfection of LMP1 in the splenocytes derived from Brown-Norway rats with or without immunization with 2,4-dinitrophenyl-conjugated Ascaris suum antigen. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40